NCT04352751 - Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions

Covid-19

Interventions

OTHER

convalescent plasma

"* Plasmapheresis, 900 - 1000 mL each time.~* Standard apheresis plasma collection protocol using Haemonetics MCS+ intermittent blood flow system or Terumo Optia, Cobe-Spectra, Trima or Fresenius continuous flow system to be used.~* Isovolumic saline replacement should be done.~* Each donor can donate convalescent plasma again after an interval of every 2 weeks"

Trial Locations (1)

75300

RECRUITING

National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD), Karachi